LRND
NYLI U.S. Large Cap R&D Leaders ETF
Price Chart
Latest Quote
$46.92
+0.83 (+1.80%)
Current Price
| Previous Close | $46.09 |
| Open | $46.92 |
| Day High | $46.92 |
| Day Low | $46.92 |
| Volume | 143 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.31% |
| Net Assets | $455.77M |
| Expense Ratio | 0.14% |
| Category | Large Growth |
| Fund Family | New York Life Investment Management LLC |
| Net Asset Value | $46.83 |
| Premium/Discount | 0.18% |
| Quarterly Dividend Yield | 0.31% |
| P/E Ratio | 28.21 |
| Exchange | NGM |
📊 ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $47.70 |
| SMA50 | $47.06 |
| SMA200 | $43.33 |
| RSI | 36.49 |
| ATR | 0.4702 |
| Rel Volume | 0.01 |
Performance History
| Week | -1.24% |
| Month | -1.41% |
| Quarter | +6.40% |
| 6 Months | +12.21% |
| YTD | +15.71% |
| Year | +14.19% |
| 3 Years | +93.81% |
| 10 Years | +96.50% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-28 | $46.92 | 143 |
| 2026-10-27 | $46.84 | 100 |
| 2026-10-26 | $46.35 | 200 |
| 2026-10-23 | $46.00 | 5,800 |
| 2026-10-22 | $46.17 | 600 |
| 2026-10-21 | $47.51 | 300 |
| 2026-10-20 | $47.06 | 100 |
| 2026-10-19 | $47.13 | 300 |
| 2026-10-16 | $46.65 | 200 |
| 2026-10-15 | $47.72 | 499,800 |
| 2026-10-14 | $47.74 | 300 |
| 2026-10-13 | $48.70 | 2,800 |
| 2026-10-12 | $48.65 | 800 |
| 2026-10-09 | $48.81 | 100 |
| 2026-10-08 | $48.52 | 1,000 |
| 2026-10-07 | $49.14 | 1,400 |
| 2026-10-06 | $49.16 | 3,200 |
| 2026-10-05 | $48.74 | 700 |
| 2026-10-02 | $48.33 | 200 |
| 2026-10-01 | $47.78 | 100 |
| 2026-09-30 | $47.80 | 200 |
| 2026-09-29 | $47.59 | 1,200 |
About NYLI U.S. Large Cap R&D Leaders ETF
The index uses a screening process to exclude companies in sectors where R&D investments have historically had less impact on a company’s performance, and to identify companies that have exhibited a strong commitment for long term growth by reinvesting in R&D. The fund will, under normal circumstances, invest at least 80% of its assets in securities of U.S. large-capitalization issuers determined to be R&D Leaders. The fund is non-diversified.
📰 Latest News
No news articles available at the moment. Check back later for updates on LRND.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.